NIDA Boss Touts Addiction Studies

Editor's Note: Scientists looking for a crash course in effective communication of their research findings should catch Alan Leshner in action. During recent months, the personable director of the Rockville, Md.-based National Institute on Drug Abuse (NIDA) has been moderating a series of "Town Meetings" in such metropolises as Philadelphia, Dallas, Chicago, and Atlanta. In the keynote talk he gives on the myths and realities of drug abuse and addiction, he juxtaposes graphs and cartoons with a

Written bySteve Bunk
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Editor's Note: Scientists looking for a crash course in effective communication of their research findings should catch Alan Leshner in action. During recent months, the personable director of the Rockville, Md.-based National Institute on Drug Abuse (NIDA) has been moderating a series of "Town Meetings" in such metropolises as Philadelphia, Dallas, Chicago, and Atlanta. In the keynote talk he gives on the myths and realities of drug abuse and addiction, he juxtaposes graphs and cartoons with anecdotes, jokes, and research findings (NIDA funds more than 85 percent of the world's research on health aspects of drug abuse and addiction), keeping large audiences rapt.

Leshner supports his central message-that drug addiction is a chronic, relapsing brain disease-with such ear-catching sound bites as, "We know more about drugs in the brain that we know about anything in the brain." Listeners tend to nod in agreement when he declares, "Drugs hijack the brain." ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA